- Home
- / SD BIOTECHNOLOGIES
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
SD BIOTECHNOLOGIES financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
₩500.1
2024-10-29
Market Capitalization
₩54.9 B
2024-07-23
Revenue
₩30.1 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| KRW | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 156.6B | 156.3B | 140.7B | 124.7B | 93.7B | 46.9B | 34.5B | 30.1B |
| Cost of goods sold | 81.2B | 104.8B | 82.3B | 85.0B | 66.0B | 26.4B | 19.3B | 16.7B |
| Gross profit | 76.2B | 54.0B | 59.5B | 40.6B | 28.3B | 28.8B | 15.8B | 13.6B |
| Gross profit margin, % | 34.6% | 42.3% | 32.6% | 30.2% | 61.4% | 46.0% | 45.1% | |
| Operating expense total | 63.1B | 65.6B | 58.7B | 70.6B | 60.2B | 31.0B | 23.2B | 18.4B |
| Depreciation and amortization | 2.0B | 6.2B | 5.2B | 10.3B | 20.5B | 3.4B | 1.2B | 773.5M |
| EBITDA | 13.3B | (11.6B) | 733.2M | (30.1B) | (31.0B) | (2.4B) | (6.5B) | (4.9B) |
| EBITDA margin, % | -7.4% | 0.5% | -24.1% | -33.1% | -5.1% | -18.9% | -16.4% | |
| EBIT | 10.9B | (19.7B) | (9.6B) | (42.3B) | (57.9B) | (9.4B) | (10.2B) | (6.4B) |
| EBIT margin, % | -12.6% | -6.8% | -33.9% | -61.8% | -20.1% | -29.6% | -21.1% | |
| Interest income | 633.1M | 648.5M | 418.7M | 243.6M | 325.0M | 634.5M | 584.2M | 348.8M |
| Interest expense | 399.2M | 573.5M | 806.1M | 3.0B | 4.4B | 4.3B | 3.4B | 1.2B |
| Pre tax profit | 11.1B | (19.8B) | (9.2B) | (42.1B) | (52.0B) | (10.0B) | (13.0B) | (6.8B) |
| Income tax expense | 2.6B | 2.2B | 530.1M | 3.0B | 2.6M | 524.0K | 2.5M | (1.4B) |
| Net Income | 8.5B | (22.0B) | (9.8B) | (45.1B) | (52.0B) | (10.0B) | (13.1B) | (5.4B) |